Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Anaxagoras who wrote (1730)	1/15/1998 1:10:00 PM
From: Tokyo VD	Read Replies (1) \| Respond to of 7041

Anax, I know what Joe said about other pharm's interest (term sheets), but since we have some questions floating about management's integrity, I'm wondering why you wouldn't question what Joe says about other pharm's interest in Vasomax. In fact, it seems logical that you would question mgmt's veracity given the information that has come out about the product and the trials. Furthermore, since you are asking others for "evidence" about SGP's due diligence what evidence do you have that these pharms were really interested (other than Joe's word)? Tokyo